Clinical Trial Update: A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating SHR-1707 infusion in patients with Alzheimer's-related cognitive impairment (mild cognitive impairment due to Alzheimer's disease and m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• SHR-1707

Snippet

Sponsor: Atridia Pty Ltd. | Conditions: Alzheimer's Disease (AD) | Phase 1 | Status: COMPLETED